Duncan Paterson, CEng, MBA, Senior Director, Device Development, AstraZeneca, discusses how pharmaceutical companies can embed environmental sustainability practices in business processes, the challenges to achieving sustainability goals and new technologies that can lower costs and environmental footprint.
